152 related articles for article (PubMed ID: 36038258)
1. First estimates of diffuse gastric cancer risks for carriers of
Coudert M; Drouet Y; Delhomelle H; Svrcek M; Benusiglio PR; Coulet F; Clark DF; Katona BW; van Hest LP; van der Kolk LE; Cats A; van Dieren JM; Nehoray B; Slavin T; Spier I; Hüneburg R; Lobo S; Oliveira C; Boussemart L; Masson L; Chiesa J; Schwartz M; Buecher B; Golmard L; Bouvier AM; Bonadona V; Stoppa-Lyonnet D; Lasset C; Colas C
J Med Genet; 2022 Dec; 59(12):1189-1195. PubMed ID: 36038258
[TBL] [Abstract][Full Text] [Related]
2. Cancer predisposition and germline CTNNA1 variants.
Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
[TBL] [Abstract][Full Text] [Related]
3. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.
Hansford S; Kaurah P; Li-Chang H; Woo M; Senz J; Pinheiro H; Schrader KA; Schaeffer DF; Shumansky K; Zogopoulos G; Santos TA; Claro I; Carvalho J; Nielsen C; Padilla S; Lum A; Talhouk A; Baker-Lange K; Richardson S; Lewis I; Lindor NM; Pennell E; MacMillan A; Fernandez B; Keller G; Lynch H; Shah SP; Guilford P; Gallinger S; Corso G; Roviello F; Caldas C; Oliveira C; Pharoah PD; Huntsman DG
JAMA Oncol; 2015 Apr; 1(1):23-32. PubMed ID: 26182300
[TBL] [Abstract][Full Text] [Related]
4. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
6. An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.
Majewski IJ; Kluijt I; Cats A; Scerri TS; de Jong D; Kluin RJ; Hansford S; Hogervorst FB; Bosma AJ; Hofland I; Winter M; Huntsman D; Jonkers J; Bahlo M; Bernards R
J Pathol; 2013 Mar; 229(4):621-9. PubMed ID: 23208944
[TBL] [Abstract][Full Text] [Related]
7. Hereditary Diffuse Gastric Cancer: A Comparative Cohort Study According to Pathogenic Variant Status.
Marwitz T; Hüneburg R; Spier I; Lau JF; Kristiansen G; Lingohr P; Kalff JC; Aretz S; Nattermann J; Strassburg CP
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322525
[TBL] [Abstract][Full Text] [Related]
8. Hereditary Diffuse Gastric Cancer.
Decourtye-Espiard L; Guilford P
Gastroenterology; 2023 Apr; 164(5):719-735. PubMed ID: 36740198
[TBL] [Abstract][Full Text] [Related]
9. Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer.
Clark DF; Michalski ST; Tondon R; Nehoray B; Ebrahimzadeh J; Hughes SK; Soper ER; Domchek SM; Rustgi AK; Pineda-Alvarez D; Anderson MJ; Katona BW
Genet Med; 2020 May; 22(5):840-846. PubMed ID: 32051609
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and cancer risk in families with pathogenic
Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of CTNNA1 germline mutations in asymptomatic carriers.
Benusiglio PR; Colas C; Guillerm E; Canard A; Delhomelle H; Warcoin M; Bellanger J; Eyries M; Zizi M; Netter J; Soubrier F; Parc Y; Mourregot A; Maran Gonzalez A; Cusin V; Denis JA; Coupier I; Svrcek M; Coulet F
Gastric Cancer; 2019 Jul; 22(4):899-903. PubMed ID: 30515673
[TBL] [Abstract][Full Text] [Related]
12. Catenin family genes are not commonly mutated in hereditary diffuse gastric cancer.
Schuetz JM; Leach S; Kaurah P; Jeyes J; Butterfield Y; Huntsman D; Brooks-Wilson AR
Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2272-4. PubMed ID: 23071139
[TBL] [Abstract][Full Text] [Related]
13. Role of germline aberrations affecting
Weren RDA; van der Post RS; Vogelaar IP; van Krieken JH; Spruijt L; Lubinski J; Jakubowska A; Teodorczyk U; Aalfs CM; van Hest LP; Oliveira C; Kamping EJ; Schackert HK; Ranzani GN; Gómez García EB; Hes FJ; Holinski-Feder E; Genuardi M; Ausems MGEM; Sijmons RH; Wagner A; van der Kolk LE; Cats A; Bjørnevoll I; Hoogerbrugge N; Ligtenberg MJL
J Med Genet; 2018 Oct; 55(10):669-674. PubMed ID: 29330337
[TBL] [Abstract][Full Text] [Related]
14. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
Kheirollahi M; Saneipour M; Moridnia A
J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
[TBL] [Abstract][Full Text] [Related]
15. Genetic predisposition to gastric cancer.
Petrovchich I; Ford JM
Semin Oncol; 2016 Oct; 43(5):554-559. PubMed ID: 27899187
[TBL] [Abstract][Full Text] [Related]
16.
Ben Aissa-Haj J; Kabbage M; Othmen H; Saulnier P; Kettiti HT; Jaballah-Gabteni A; Ferah A; Medhioub M; Khsiba A; Mahmoudi M; Maaloul A; Ben Nasr S; Chelbi E; Abdelhak S; Boubaker MS; Azzouz MM; Rouleau E
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327954
[TBL] [Abstract][Full Text] [Related]
17. Hereditary diffuse gastric cancer (HDGC). An overview.
Taja-Chayeb L; Vidal-Millán S; Trejo-Becerril C; Pérez-Cárdenas E; Chávez-Blanco A; Domínguez-Gómez G; González-Fierro A; Romo-Pérez A; Dueñas-González A
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101820. PubMed ID: 34656755
[TBL] [Abstract][Full Text] [Related]
18. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families.
Pharoah PD; Guilford P; Caldas C;
Gastroenterology; 2001 Dec; 121(6):1348-53. PubMed ID: 11729114
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
20. Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer.
Aronson M; Swallow C; Govindarajan A; Semotiuk K; Cohen Z; Kaurah P; Velsher L; Ambus I; Buckley K; Forster-Gibson C; Meschino WS; Blumenthal A; Kim RH; Brar S
Curr Oncol; 2020 Apr; 27(2):e182-e190. PubMed ID: 32489267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
